A recent study lead by researchers at Massachusetts General Hospital (MA, USA) has highlighted a novel mechanism behind resistance to angiogenesis inhibitors.
Researchers have discovered the ability of cancer cells to force the fibroblasts in a tumor to mimic a viral infection, allowing tumors to spread and respond to attack with greater efficacy.
Researchers have demonstrated a previously undefined role of histone deacetylase 11 (HDAC11), in regulating T-cell effector functions.
Researchers have uncovered the role of cellular prion protein (PrPC) in Neurofibromatosis Type 2 (NF2) related tumors, offering hope to neuro-tumor patients.
A tumor-targeting Magnetic Resonance Imaging (MRI) contrast, based on human proteins has been designed, that is also cleared easily by the body. The development has promise for clinical application.
Researchers have developed a nurse-led intervention to help carers with medication management and evaluated its use in routine practice.
Researchers have highlighted the potential of liquid biopsy’s ability to further our understanding of why in some individuals, cancer treatments lose effectiveness.
Researchers have unearthed molecular changes along the digestive tract that could aid the development of targeted therapies.
Data has demonstrated that a novel immunotherapy is generally well tolerated and exhibits preliminary evidence of anti-tumor activity in hepatocellular carcinoma patients.
A new assay test for five cancer-associated genes with the goal of aiding prediction of neuroblastoma in children has been reported.